Besides, it has been widely documented that the genetic alterations in GSK-3β impinge on the tumorigenesis, tumor development, epithelial–mesenchymal transition, and cancer metastasis, as well as therapy resistance in multiple cancers [28]. The gene discussed is GSK3B; the disease is cancer.